Clinical trial
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen…
NCT00283608 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00283608 |
|---|---|
| Title | Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer |
| Official title | Pharmacogenetics of Aromatase Inhibitors |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Genetic, Other |
| Interventions | Single nucleotide polymorphism (SNP), high performance liquid chromatography, measurements by DXA, questionnaire administration |
| Enrollment | 1,000 |
| Start date | Jul 1, 2005 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jan 30, 2006 |
| Last update posted | May 16, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: